Adult Leukemia: What You Need to Know

More than 60,000 new cases of adult leukemia are diagnosed in the U.S. each year. Although it is one of the more common childhood cancers, leukemia occurs more often in older adults. How does leukemia develop in adults? Leukemia is a cancer of the body’s blood-forming tissues that results in large numbers of abnormal or immature white blood … Read more

Bone Cancer in Children: What are the Latest Treatment Options?

Medically reviewed by Katherine A. Janeway, MD Cancer affecting the bones may be primary (a cancer that develops within the bone) or metastatic (spreading to bones from elsewhere in the body). Many primary bone tumors are benign (noncancerous), but others are malignant. Treatment options for bone tumors include surgery, chemotherapy, radiation therapy, cryosurgery (freezing cancer … Read more

Making the Immune System Work Against Cancer: A Pioneering Researcher’s Journey

Bone marrow transplantation, which was first developed in the 1970s, was conceived as a way of dealing with the effects of high-dose chemotherapy for leukemia, lymphoma, and other blood-related diseases. The large doses killed diseased blood cells throughout the body but also destroyed the bone marrow, birthplace of new blood cells. By transplanting bone marrow … Read more

New Study Reports “Curative Potential” of a Combination Therapy for Some Leukemia Patients

Medically reviewed by Matthew Davids, MD, MMSc Chemoimmunotherapy combined with a targeted drug given for two years has achieved undetectable minimal residual disease (MRD) for a high proportion of younger patients with chronic lymphocytic leukemia (CLL), Dana-Farber scientists report. The phase 2 clinical trial results are so favorable that they represent a step toward “a … Read more

What’s New in the Treatment of Pediatric Leukemia?

Medically reviewed by Lewis Silverman, MD A greater understanding of the genomics of pediatric leukemia — the genetic errors and irregularities that underlie the disease — has enabled researchers to divide the disease into additional subtypes. This has improved physicians’ ability to identify patients with an increased risk of relapse and to prescribe treatments to … Read more

Hodgkin Lymphoma: The Latest in Treatment and Research

Chemotherapy has been the backbone of treatment for both untreated and relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL). But treatment paradigms for cHL are changing. Immunotherapies that unmask cancer cells and make them vulnerable to our immune system, called immune checkpoint inhibitors (ICIs), were recently approved for relapsed and refractory cHL. Examples include PD-1 inhibitors such … Read more

Understanding Your Pathology Report

If you have had a biopsy or surgery that removes tissue from your body, in almost all cases a sample will be sent to a pathology lab for examination. Pathologists, who specialize in looking at microscopic tissue samples, will look for signs of disease.  Their findings will be detailed in a pathology report. The first … Read more